Oseltamivir Phosphate

OSELTAMIVIR PHOSPHATE — oseltamivir phosphate suspension
Cadila Healthcare Limited

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

NDC 70771-1598-6

Oseltamivir Phosphate for Oral Suspension

6 mg/mL *

60 mL (usable volume after constitution)

mfg label
(click image for full-size original)
OSELTAMIVIR PHOSPHATE
oseltamivir acid suspension
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:70771-1598
Route of Administration ORAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
OSELTAMIVIR PHOSPHATE (OSELTAMIVIR ACID) OSELTAMIVIR ACID 6 mg in 1 mL
Inactive Ingredients
Ingredient Name Strength
MONOSODIUM CITRATE
SACCHARIN SODIUM
SODIUM BENZOATE
SORBITOL
TITANIUM DIOXIDE
WATER
XANTHAN GUM
Product Characteristics
Color WHITE (White) Score
Shape Size
Flavor TUTTI FRUTTI Imprint Code
Contains
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:70771-1598-6 60 mL in 1 BOTTLE None
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
ANDA ANDA209113 08/05/2021
Labeler — Cadila Healthcare Limited (918596198)
Establishment
Name Address ID/FEI Operations
CADILA HEALTHCARE LIMITED 677605858 ANALYSIS (70771-1598), MANUFACTURE (70771-1598)

Revised: 08/2021 Cadila Healthcare Limited

All MedLibrary.org resources are included in as near-original form as possible, meaning that the information from the original provider has been rendered here with only typographical or stylistic modifications and not with any substantive alterations of content, meaning or intent.

This site is provided for educational and informational purposes only, in accordance with our Terms of Use, and is not intended as a substitute for the advice of a medical doctor, nurse, nurse practitioner or other qualified health professional.

Privacy Policy | Copyright © 2022. All Rights Reserved.